Clinical Trial: A prospective, multicenter, randomized, non-treatment parallel-controlled, evaluator-blinded, superiority clinical trial study to evaluate the efficacy of recombinant type III humanized collagen-sodium hyaluronate lyophilized fiber on improving skin condition and the safety and efficacy of clinical application (China)

China, Sept. 9 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A prospective, multicenter, randomized, non-treatment parallel-controlled, evaluator-blinded, superiority clinical trial study to evaluate the efficacy of recombinant type III humanized collagen-sodium hyaluronate lyophilized fiber on improving skin condition and the safety and efficacy of clinical application'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600131990

Registration Time: 2026/09/08

Type: Interventional study

Primary Sponsor: Zhejiang Provincial People's Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=215784

Published by HT Digital...